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Abstract
A 2-year-old Malay boy was brought to the University Malaya Medical Centre for thalassaemia
screening. Physical examination revealed thalassaemia facies, pallor, mild jaundice, hepatomegaly
and splenomegaly. Laboratory investigations on the patient including studies on the parents lead to
a presumptive diagnosis of homozygous Haemoglobin Lepore (Hb Lepore). The aim of this paper
is to increase awareness of this rare disorder, this being the first case documented in Malaysia in a
Malay. The case also demonstrates the need for this disorder to be included in the differential
diagnosis of patients presenting clinically like thalassemia intermedia or thalassemia major. Accurate
diagnosis would provide information necessary for prenatal diagnosis, proper clinical management
and genetic counseling. The clinical, haematological and laboratory features of this disorder are
discussed in this paper.
Key words:  Haemoglobin Lepore, Thalassaemia-like disorder
INTRODUCTION
Haemoglobin Lepore is a structurally abnormal
haemoglobin in which the abnormal globin chain
is a hybrid or fused globin chain that has the N-
terminal amino acid sequence of a delta chain
and the C- terminal amino acid sequence of a
beta chain.1 This abnormal globin chain is the
product of a hybrid gene that results from an
unequal crossing over between the delta and beta
globin genes because of a misalignment of
homologous chromosome during meiosis. This
leads to a 7.4 kb deletion between the delta and
beta globin genes.1, 2
       Three different Lepore haemoglobins have
been identified so far and they are characterized
by different delta to beta sequence transitions at
the fusion junction.1,2,3   Hb Lepore Washington
Boston (δ87/β116), Hb Lepore Hollandia (δ22/
β50), Hb Lepore Baltimore (δ50/β86).  Hb Lepore
Washington Boston is the most common and
occurs worldwide.1,2  Hb Lepore Baltimore was
first described in one family with black ancestry
from Baltimore, and afterwards in Yugoslavia,
Spain and Northern Sardinia.  Hb Lepore
Hollandia is a rare variant and has been found in
New Guinea, Bangladesh and in Thailand.2,3   In
all three variants, the synthesis of these hybrid
chains is substantially less than that of the beta
chains, resulting in an overall reduction in the
non alpha globin chains and having clinically a
beta thalassaemia-like condition. However, the
Hb Lepore condition can be differentiated from
a beta thalassaemia by the presence of the distinct
Hb Lepore band on cellulose acetate
electrophoresis.4,5
       There are numerous large series and single
case reports describing the heterozygous state
for Hb Lepore and compound heterozygous state
for Hb Lepore with thalassemia and other
haemoglobinopathies.  However homozygous Hb
Lepore has been rarely reported, with only 22
patients recognized worldwide.5  This report is
the first case documented in Malaysia in a Malay.
      The aim of this paper is to increase awareness
of this rare disorder which should be included in
the differential diagnosis of patients presenting
clinically like a mild or severe thalassaemia
intermedia/major, to provide accurate prenatal
diagnosis, proper clinical management and
genetic counseling. We describe a 2-year-old
Malay boy whose clinical presentation was like
a beta thalassaemia major. Laboratory
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investigations revealed the diagnosis to be
homozygous Haemoglobin Lepore.  The clinical,
haematological and laboratory features of this
disorder are discussed in this paper.
CASE REPORT
A 2-year-old Malay boy was brought to
University Malaya Medical Centre for
thalassemia/ haemoglobinopathy screening.
Physical examination revealed thalassemia
facies, pallor, mild jaundice, hepatomegaly (3
cm below the right subcostal margin) and
splenomegaly (3 cm below the left subcostal
margin). His height was at 3rd percentile and his
weight was at 3-10th percentile.   His
haematological profile showed haemoglobin 74
g/L, red cell count 3.3 x 10 12 L, MCV 77 fl,
MCH 22 pg and a reticulocyte count of 5.8%.
The white blood cell count and platelet count
were normal. The patient’s blood smear revealed
hypochromia, microcytosis, anisopoikilocytosis,
polychromasia, basophilic stippling and a few
target cells (Fig.1).
Haemoglobin electrophoresis on cellulose
acetate at alkaline pH (pH 8.6) showed a
prominent F band and an additional band in the
S region (Fig. 2). There was no haemoglobin A
or haemoglobin A2 bands seen. Quantification
of haemoglobin F revealed a level of 90% and
the unknown haemoglobin constituted 9.3%.
Electrophoresis at acid pH (pH 6.0) on citrate
agar was carried out to identify the band in the
S region. There was no Hb S detected.  However,
a prominent band was noted in the F region and
a faint band in the A region. As the patient did
not have any A band on the cellulose acetate
strip, the faint band in the A region on citrate
agar was suggestive of Hb D/G or Hb Lepore.
Further testing to identify and quantify the
abnormal haemoglobin variant was carried out
by high performance liquid chromatography
(HPLC) Bio-Rad Variant Haemoglobin testing
system (Fig. 3). The unknown haemoglobin had
a retention time (RT=3.59) similar to Hb A2 on
the “Beta Thal Short Program” and was
quantified as 10.7 %.  There was no haemoglobin
A synthesized and  the rest of the haemoglobin
present was hemoglobin F.  Hb Lepore is known
to have the same retention  time as  Hb A2 on the
“Beta Thal Short Program” and therefore a
presumptive diagnosis of  homozygous Hb
Lepore  was made for the patient.
Screening was carried out for both parents.
The father’s blood studies showed haemoglobin
140 g/L, MCV 72 fl, and MCH 24 pg while the
mother’s haemoglobin was 111g/L, MCV 65.0fl,
MCH 19 pg.  The blood smear of both parents
revealed hypochromia, microcytosis, few target
cells and occasional basophilic stippling (Fig.
4).  Haemoglobin electrophoresis on cellulose
acetate (pH 8.6) of both parents (Fig. 5) showed
bands at A, A2, and F regions and an additional
band in the S region while electrophoresis on
citrate agar at acid pH showed a prominent A
band and a faint band in the F region. There was
FIG. 1: Peripheral blood film of patient showing
hypochromasia, microcytosis, anisopoikilo-
cytosis, target cells and nucleated red blood
cell. Wright stain X 400
FIG. 2: Haemoglobin electrophoresis on cellulose ac-
etate at pH 8.6 Lane 1: normal control show-
ing Hb A and Hb A2.   Lane 2: patient:
absence of Hb A and Hb A2, increased Hb F
and an abnormal Hb (unknown band).
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FIG. 3: High performance liquid chromatography
analysis using the VARIANT Hemoglobin
Testing System (Bio-Rad Laboratories).
Chromatogram of patient (homozygous).  No
Hb A, increased Hb F,  Hb A2 + Lepore
retention time 3.59
FIG. 4: Peripheral blood film (mother) showing
hypochromasia, microcytosis and target cells.
Wright stain x 400
FIG. 6: High performance liquid chromatography
analysis using the VARIANT Hemoglobin
Testing System (Bio-Rad Laboratories) .
Chromatogram of mother (heterozygous). Hb
A2 + Lepore retention time 3.59
FIG. 5: Haemoglobin electrophoresis on cellulose
acetate at pH 8.6.  Lane 1: normal control
showing Hb A and Hb A2.  Lane2: mother,
heterozygous showing HbA, Hb A2 and an
abnormal Hb (unknown).  Lane 3: father,
heterozygous showing similar findings.
no Hb S detected.   The father’s Hb F level was
1.6%, Hb A2 level 2.7% while the mother’s Hb
F level was 2.1%, Hb A2 level 3.0 %. High
performance liquid chromatography (Fig. 6)
revealed the unknown haemoglobin to be Hb
Lepore (RT= 3.59) and the level in the father
and mother was 13.1% and 13.8% respectively.
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A diagnosis of heterozygous haemoglobin
Lepore was made for both parents. The parents
are first degree relatives. The patient’s and
parents’ samples were sent for DNA sequencing
which confirmed this unknown haemoglobin to
be Hb Lepore Washington Boston. The patient
is on regular follow-up and has received 3 blood
transfusions at 4 -5 monthly intervals since the
time of diagnosis.
DISCUSSION
Hb Lepore is a common abnormal haemoglobin
seen in the Mediterranean region. It is the most
common abnormal haemoglobin in Caucasians
in Central Portugal and in the Spanish Alta
Extremadura.1  It is a variant form of human
haemoglobin that contains delta beta hybrid
chains or a fused globin chain, from the product
of a hybrid gene: the unequal crossing over
between the delta and beta globin genes resulting
in a deletion of 7.4kb in the beta globin gene
cluster.1,2
Three different types of Hb Lepore have been
described so far, each with a different crossover
breakpoint: Hb Lepore Washington Boston, Hb
Lepore Baltimore and Hb Hollandia.1,2,4  The
basic defect in all the Hb Lepore disorders is the
inefficient synthesis of the delta beta fusion
chains of Hb Lepore, which leads to a variable
degree of globin imbalance, excess alpha chain
production and the clinical phenotype of beta
thalassaemia. The ineffective erythropoiesis and
the shortened red cell survival results from the
deleterious effects of excess alpha chains.  The
selection of cells which are synthesizing
relatively more gamma chains follow the same
mechanism as occurs in beta thalassemia.5 It has
been postulated that the deletion which resulted
in the delta beta fusion is somehow responsible
for increasing the absolute output of gamma
chains.6  This is compatible with the observation
that Hb Lepore heterozygotes produce
significantly more Hb F than beta thalassaemia
heterozygotes.
The Hb Lepore heterozygotes are usually
asymptomatic. In a large Italian series no
abnormal physical signs were reported, but a
few of the Greek and Yugoslavian heterozygotes
had mild splenomegaly.7,8  Heterozyogotes are
therefore healthy individuals with only a slight
decrease in haemoglobin levels, but with a
distinct microcytosis and hypochromia of their
red blood cells. The mean cell haemoglobin
(MCH) is thought  to be the most reliable
parameter that is altered in the Hb Lepore
heterozygotes (range 20-25 pg).9 In this series,
the red cell indicies  and morphological
appearances of the blood film of beta
thalassaemic carriers were compared with  that
of heterozygous Hb Lepore.  It was found to be
similar in both conditions. Studies suggest that
there are no major differences in the
haematological findings between carriers of the
different molecular varieties of Hb Lepore.1 Red
cell survival and ferrokinetic data available reveal
red cell survival is slightly shortened and Fe 59
utilization is increased.10
The Hb Lepore homozygotes vary in the
severity of their clinical manifestations.6,7,8 At
one end of the spectrum are patients who present
within the first 5 years of life with severe anaemia
with haemoglobin values ranging from 4 to 7 g/
dl. Significant splenomegaly, hepatomegaly, and
skeletal abnormalities indistinguishable from
those of homozygous beta thalassaemia are seen.
These patients require regular blood transfusion
and exhibit shortened life span. At the other end
of the spectrum are patients   who have a milder
disorder indistinguishable from beta thalassemia
intermedia, who are anaemic throughout
childhood and require only occasional blood
transfusions. The homozygous state for Hb
Lepore therefore varies from a transfusion
dependent disease like beta thalassaemia major
through the milder spectrum of thalasaemia
intermedia that appears to be compatible with
longevity of life.5 The haematological findings
in these patients are peripheral blood film features
indistinguishable from the severe forms of beta
thalassaemia.  Bone marrow smears show marked
erythroid hyperplasia due to high level of
erythropoietin production in response to the
anaemia.6
The multifaceted approach for the
presumptive identification of haemoglobin
variants includes a scrutiny of blood counts/red
cell indices and haemoglobin analysis. This
approach easily identifies Hb Lepore. On
cellulose acetate electrophoresis at alkaline pH,
Hb Lepore shows electrophoretic mobility
similar to Hb S.5 The other haemoglobins that
run in this position are Hb D and Hb G, which
are differentiated from Hb S by sickle solubility
test and electrophoresis at acid pH.  Hb Lepore
has a similar retention time (RT) value as Hb A2
on high performance liquid chromatography
(HPLC) analysis with the Bio-Rad Variant
Haemoglobin testing system.2 Values greater
than 10% suggest the presence of variant
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haemoglobin. In Malaysia the most common
haemoglobin variant seen is Hb E that is
differentiated from Hb Lepore by cellulose
acetate electrophoresis at alkaline pH.  Hb E
runs in the same position as HbA2, whereas Hb
Lepore runs at the position of Hb S. Therefore a
multifaceted approach which includes
haemoglobin electrophoresis and high
performance liquid chromatography provides
sufficient information for the presumptive
identification of Hb Lepore. The characterisation
of the type of Hb Lepore requires analysis of the
globin chains by reversed phase HPLC and
DNA studies would confirm the diagnosis of
this variant haemoglobin.4
In the homozygous state, Hb A and Hb A2
are absent and the haemoglobin is made up of
Hbs F and Lepore only. The level of Hb Lepore
ranges from 8 to 30% with a mean value of
approximately 15%, the remainder of the
haemoglobin being Hb F. In the heterozygous
state the haemoglobin contains Hbs A, Lepore,
A2 and a variable amount of Hb F. The reported
level of Hb Lepore is between 5 to 15%, with a
mean level around 10%. The mean level of Hb
A2 is about 2% and the reported values for Hb
F range from between 1-14%.5
In conclusion, Hb Lepore is a structural
haemoglobin variant coded for by a hybrid gene
formed by the fusion of delta and beta genes.
The homozygous state is clinically similar to
beta thalassaemia intermedia or major.
Presumptive identification can be easily made
in the laboratory by a multifaceted approach that
includes the methods, scrutiny of blood counts/
red cell indices, haemoglobin electrophoresis at
alkaline and acid pH and haemoglobin analysis
by high performance liquid chromatography.
However, confirmation requires DNA
characterization. A correct diagnosis is essential
for proper clinical management and genetic
counseling.
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